dehydroepiandrosterone has been researched along with Astrocytoma, Grade IV in 2 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SJ | 3 |
| Park, SJ | 3 |
| Park, J | 3 |
| Cho, HJ | 3 |
| Shim, JK | 3 |
| Seon, J | 3 |
| Choi, RJ | 3 |
| Yoon, SJ | 3 |
| Moon, JH | 3 |
| Kim, EH | 3 |
| Seo, EK | 3 |
| Kim, SH | 3 |
| Kim, HS | 3 |
| Teo, WY | 3 |
| Chang, JH | 3 |
| Yook, JI | 3 |
| Kang, SG | 3 |
| Yang, WB | 1 |
| Chuang, JY | 1 |
| Ko, CY | 1 |
| Chang, WC | 1 |
| Hsu, TI | 1 |
2 other studies available for dehydroepiandrosterone and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G | 2022 |
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G | 2022 |
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G | 2022 |
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G | 2022 |
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G | 2022 |
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G | 2022 |
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G | 2022 |
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G | 2022 |
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G | 2022 |
Dehydroepiandrosterone Induces Temozolomide Resistance Through Modulating Phosphorylation and Acetylation of Sp1 in Glioblastoma.
Topics: Acetylation; Brain Neoplasms; Cell Line, Tumor; Cell Nucleus; Dehydroepiandrosterone; DNA Damage; Dr | 2019 |